As of Oct 21
| +0.0029 / +0.34%|
The 1 analysts offering 12-month price forecasts for Navidea Biopharmaceuticals Inc have a median target of 2.40, with a high estimate of 2.40 and a low estimate of 2.40. The median estimate represents a +178.75% increase from the last price of 0.86.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.